BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8328094)

  • 21. Carcinoma ex pleomorphic adenoma of the parotid gland. Study and implications for diagnostics and therapy.
    Lüers JC; Wittekindt C; Streppel M; Guntinas-Lichius O
    Acta Oncol; 2009; 48(1):132-6. PubMed ID: 18607845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors of tracheobronchial mucoepidermoid carcinoma--15 years experience.
    Chin CH; Huang CC; Lin MC; Chao TY; Liu SF
    Respirology; 2008 Mar; 13(2):275-80. PubMed ID: 18339028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parotid cancer in Auckland 1970-1986--too little, too late.
    Humberstone DA; Levestrom M; Shaw JH
    N Z Med J; 1987 Nov; 100(836):703-5. PubMed ID: 3452162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic analysis of adenoid cystic carcinoma of major salivary glands of 64 cases].
    Qing J; Zhang Q; Wei MW; Guo ZM
    Ai Zheng; 2006 Sep; 25(9):1138-43. PubMed ID: 16965658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Facial nerve function in carcinoma of the parotid gland.
    Terhaard C; Lubsen H; Tan B; Merkx T; van der Laan B; Baatenburg de Jong R; Manni H; Knegt P
    Eur J Cancer; 2006 Nov; 42(16):2744-50. PubMed ID: 16950616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parotid carcinoma: impact of clinical factors on prognosis in a histologically revised series.
    Godballe C; Schultz JH; Krogdahl A; Møller-Grøntved A; Johansen J
    Laryngoscope; 2003 Aug; 113(8):1411-7. PubMed ID: 12897568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant epithelial parotid gland tumours: analysis and results in 65 previously untreated patients.
    Leverstein H; van der Wal JE; Tiwari RM; Tobi H; van der Waal I; Mehta DM; Snow GB
    Br J Surg; 1998 Sep; 85(9):1267-72. PubMed ID: 9752874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic indicators for malignant tumours of the parotid gland.
    Harbo G; Bundgaard T; Pedersen D; Søgaard H; Overgaard J
    Clin Otolaryngol Allied Sci; 2002 Dec; 27(6):512-6. PubMed ID: 12472522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors and outcome for nasopharyngeal carcinoma.
    Farias TP; Dias FL; Lima RA; Kligerman J; de Sá GM; Barbosa MM; Gonçalves FB
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):794-9. PubMed ID: 12874084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of adenoid cystic carcinoma of minor salivary glands.
    Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Koufogiannis D
    J Oral Maxillofac Surg; 2006 Jul; 64(7):1114-20. PubMed ID: 16781345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience.
    Gomez DR; Hoppe BS; Wolden SL; Zhung JE; Patel SG; Kraus DH; Shah JP; Ghossein RA; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1365-72. PubMed ID: 18029108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatments and outcomes of malignant tumors of external auditory canal.
    Chang CH; Shu MT; Lee JC; Leu YS; Chen YC; Lee KS
    Am J Otolaryngol; 2009; 30(1):44-8. PubMed ID: 19027512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for distant metastases from carcinoma of the parotid gland.
    Gallo O; Franchi A; Bottai GV; Fini-Storchi I; Tesi G; Boddi V
    Cancer; 1997 Sep; 80(5):844-51. PubMed ID: 9307182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
    Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Facial nerve damage in the treatment of tumours of the parotid gland.
    Rampling R; Catterall M
    Clin Oncol; 1984 Dec; 10(4):345-51. PubMed ID: 6096056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience.
    Wong WW; Schild SE; Halyard MY; Schomberg PJ
    J Surg Oncol; 2002 May; 80(1):19-25; discussion 26. PubMed ID: 11967901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucoepidermoid carcinoma of the parotid gland in children: A 10-year experience.
    Rahbar R; Grimmer JF; Vargas SO; Robson CD; Mack JW; Perez-Atayde AR; Marcus KJ; Grier HE; Healy GB; McGill TJ
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):375-80. PubMed ID: 16618905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucoepidermoid carcinoma of the parotid gland: the Mayo clinic experience.
    Boahene DK; Olsen KD; Lewis JE; Pinheiro AD; Pankratz VS; Bagniewski SM
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):849-56. PubMed ID: 15262762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.